Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes

被引：0
|
作者：
Zou, Qi
Engstrom, Gunnar
Pan, Jingxue
Zhang, Jialin
Perisho, Esther J.
Lin, Yanzhu
Wiese, Russell
Wilson, Jonathan M.
Pavo, Imre
Gao, Rui
Duffin, Kevin L.
De Marinis, Yang
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-741-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
741-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2464 - 2464
  • [32] Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes
    Louis S. Matza
    Katie D. Stewart
    Laura Fernández Landó
    Hiren Patel
    Kristina S. Boye
    The Patient - Patient-Centered Outcomes Research, 2022, 15 : 367 - 377
  • [33] Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes
    Chauhan, Kinsuk
    Verghese, Divya Anna
    Rao, Veena
    Chan, Lili
    Parikh, Chirag R.
    Coca, Steven G.
    Nadkarni, Girish N.
    KIDNEY INTERNATIONAL, 2019, 95 (02) : 439 - 446
  • [34] Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?
    Razzaki, Tanzila S.
    Weiner, Alyson
    Shukla, Alpana P.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 955 - 964
  • [35] Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes
    Matza, Louis S.
    Stewart, Katie D.
    Lando, Laura Fernandez
    Patel, Hiren
    Boye, Kristina S.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2022, 15 (03): : 367 - 377
  • [36] Early Weight Loss and Late Metabolic Outcomes in Tirzepatide-Treated Participants with Type 2 Diabetes
    Lingvay, Ildiko
    Giorgino, Francesco
    Van Gaal, Luc
    Liu, Minzhi
    Rodriguez, Angel
    Torcello-Gomez, Amelia
    Kiljanski, Jacek I.
    DIABETES, 2023, 72
  • [37] The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
    Lempesis, Ioannis G.
    Liu, Junli
    Dalamaga, Maria
    METABOLISM OPEN, 2022, 16
  • [38] Sodium Intake, Circulating Microvesicles and Cardiovascular Outcomes in Type 2 Diabetes
    Liu, Dorothy
    Baqar, Sara
    Lincz, Lisa L.
    Ekinci, Elif, I
    CURRENT DIABETES REVIEWS, 2019, 15 (06) : 435 - 445
  • [39] Comparison of different doses of tirzepatide and semaglutide in type 2 diabetes
    Kahl, S.
    DIABETOLOGIE, 2022, 18 (06): : 756 - 757
  • [40] Use of Tirzepatide in Type 1 Diabetes
    Childs, Belinda P.
    Tade, Mackenzie
    Sebes, Jennifer
    Molt, Lisa
    Childs, Allison
    DIABETES, 2024, 73
12345